Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bridges

Showing results (291-300 of 403) with videos related to

Pageof 41
Sort By:
Chemmedchem|August 26, 2009
Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptorJ Phillip Kennedy, Thomas M Bridges, Patrick R Gentry, et al.
Nucleic Acids Research|November 16, 2010
AgBase: supporting functional modeling in agricultural organismsFiona M McCarthy, Cathy R Gresham, Teresia J Buza, et al.
Journal of Medicinal Chemistry|May 15, 2009
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatinsThomas M Bridges, Joy E Marlo, Colleen M Niswender, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2014
Further optimization of the M5 NAM MLPCN probe ML375: tactics and challengesHaruto Kurata, Patrick R Gentry, Masaya Kokubo, et al.
ACS Chemical Neuroscience|December 22, 2012
Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding modeGregory J Digby, Thomas J Utley, Atin Lamsal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
ACS Chemical Neuroscience|July 4, 2019
Acute Negative Allosteric Modulation of M<sub>5</sub> Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on AntinociceptionRobert W Gould, Barak W Gunter, Michael Bubser, et al.
ACS Chemical Neuroscience|November 27, 2018
Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain ModelsKristopher K Abney, Michael Bubser, Yu Du, et al.
Scandinavian Journal of Gastroenterology|March 17, 2000
Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasiaM Younes, J Lechago, S Chakraborty, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: the continued optimization of an MLPCN probe moleculeMichael S Poslusney, Bruce J Melancon, Patrick R Gentry, et al.
Pageof 41

Showing results (291-300 of 403) with videos related to

Sort By:
Pageof 41
Chemmedchem|August 26, 2009
Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptorJ Phillip Kennedy, Thomas M Bridges, Patrick R Gentry, et al.
Nucleic Acids Research|November 16, 2010
AgBase: supporting functional modeling in agricultural organismsFiona M McCarthy, Cathy R Gresham, Teresia J Buza, et al.
Journal of Medicinal Chemistry|May 15, 2009
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatinsThomas M Bridges, Joy E Marlo, Colleen M Niswender, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2014
Further optimization of the M5 NAM MLPCN probe ML375: tactics and challengesHaruto Kurata, Patrick R Gentry, Masaya Kokubo, et al.
ACS Chemical Neuroscience|December 22, 2012
Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding modeGregory J Digby, Thomas J Utley, Atin Lamsal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
ACS Chemical Neuroscience|July 4, 2019
Acute Negative Allosteric Modulation of M<sub>5</sub> Muscarinic Acetylcholine Receptors Inhibits Oxycodone Self-Administration and Cue-Induced Reactivity with No Effect on AntinociceptionRobert W Gould, Barak W Gunter, Michael Bubser, et al.
ACS Chemical Neuroscience|November 27, 2018
Analgesic Effects of the GIRK Activator, VU0466551, Alone and in Combination with Morphine in Acute and Persistent Pain ModelsKristopher K Abney, Michael Bubser, Yu Du, et al.
Scandinavian Journal of Gastroenterology|March 17, 2000
Relationship between dysplasia, p53 protein accumulation, DNA ploidy, and Glut1 overexpression in Barrett metaplasiaM Younes, J Lechago, S Chakraborty, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: the continued optimization of an MLPCN probe moleculeMichael S Poslusney, Bruce J Melancon, Patrick R Gentry, et al.
Pageof 41